IQSM:NYE-Iq Candriam ESG U.S. Mid Cap Equity ETF (USD)

ETF | Others |

Last Closing

USD 32.199

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.10K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.14 (-0.77%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.21 (+0.37%)

USD 37.29B
DFAC Dimensional U.S. Core Equity 2..

+0.10 (+0.29%)

USD 32.64B
SGOV iShares® 0-3 Month Treasury B..

+0.02 (+0.02%)

USD 30.12B
JPST JPMorgan Ultra-Short Income ET..

+0.01 (+0.02%)

USD 28.05B
DTB DTE Energy Company 2020 Series

-0.20 (-1.12%)

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

-0.92 (-1.23%)

USD 21.47B
JAAA Janus Detroit Street Trust - J..

+0.03 (+0.06%)

USD 16.68B
AVUV Avantis® U.S. Small Cap Value..

+0.80 (+0.84%)

USD 15.39B
DFUS Dimensional U.S. Equity ETF

+0.10 (+0.16%)

USD 12.89B

ETFs Containing IQSM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.81% 43% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.81% 42% F 49% F
Trailing 12 Months  
Capital Gain 8.96% 59% D- 62% D
Dividend Return 0.90% 14% F 11% F
Total Return 9.86% 56% F 56% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.08% 75% C 57% F
Dividend Return 7.47% 74% C 51% F
Total Return 0.38% 26% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 9.45% 55% F 81% B-
Risk Adjusted Return 78.98% 82% B 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.